StockData
Solventum Corp logo

Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3091% above fair value
$86.48+0.42 (+0.49%)

Close on Nov 18, 2026Market cap $14.72BP/E 97.2Yield –

Solventum gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Solventum's gross profit for the twelve months ending Sep 30, 2026 was $4.47B, down 1.6% year over year. For fiscal 2025 it was $4.45B, down 3.1% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.45B-3.1%
FY2024Dec 31, 2024$4.59B-2.1%
FY2023Dec 31, 2023$4.69B-0.0%
FY2022Dec 31, 2022$4.70B–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.06B-6.4%
Q2 FY2026Jun 30, 2026$1.29B+9.4%
Q1 FY2026Mar 31, 2026$1.10B-1.5%
Q4 FY2025Dec 31, 2025$1.03B-8.2%
Q3 FY2025Sep 30, 2025$1.14B-2.6%
Q2 FY2025Jun 30, 2025$1.18B+3.3%
Q1 FY2025Mar 31, 2025$1.11B-4.9%
Q4 FY2024Dec 31, 2024$1.12B-3.4%
Q3 FY2024Sep 30, 2024$1.17B-3.6%
Q2 FY2024Jun 30, 2024$1.14B-4.4%
Q1 FY2024Mar 31, 2024$1.17B+3.1%
Q4 FY2023Dec 31, 2023$1.16B–
Q3 FY2023Sep 30, 2023$1.21B–
Q2 FY2023Jun 30, 2023$1.19B–
Q1 FY2023Mar 31, 2023$1.14B–

More Solventum figures

See a number that looks wrong?